Medical Products and Capabilities Enhancement Activities
Abstract
Guidance for Development of the Force-Medical Products and Capabilities Enhancement Activities: Funds will support product improvements or evaluations of fielded, commercially available, or currently employed/practiced medical products, therapies, treatments, or medical guidelines to evaluate and/or improve their effectiveness. Included are development efforts to upgrade systems/products that have been fielded or that are routinely used in a fixed facility, or to upgrade systems/products that have received approval for full-rate production and for which procurement funding is anticipated in the current or subsequent fiscal years; development, engineering, and testing of changes to a fielded or procured system/product that alters its performance envelope; and analysis of data on the performance of fielded products or medical practices to identify the need or opportunity for changes. Projects will be funded that provide clinical outcome follow-ups to military unique clinical practice guidelines. In addition, medical IM/IT systems upgrades will be sought for product improvements that will integrate medical injury and autopsy data with non-medical and live fire testing data, and blast sensor field data will be analyzed to determine if the data can be used to confidently predict head injury. These IM/IT enhancements will allow improved prediction of injuries, the knowledge of which will impact improvements to fighting/support vehicles and protective equipment that will ultimately reduce injuries. Efforts address the Military Health System family of Concept of Operations documents and follow-on Capabilities Based Assessments/Joint Capability Documents, appropriate Component requirements, legislative and Executive directives (e.g., National Research Action Plan, Office of Management and Budget Combat Casualty Care Assessment, National Defense Authorization Acts, etc.) and others as appropriate.
Document Details
- Document Type
- R2 Budgetary Justification
- Publication Date
- Oct 01, 2015
- Source ID
- 0607100HP_2_0130_PB_2015
- Change Summary Explanation
- FY 2013: Realignment from Defense Health Program, Research, Development, Test and Evaluation (DHP RDT&E), PE 0607100-Medical Products and Capabilities Enhancement Activities (-$0.292 million) to DHP RDT&E PE 0605502-Small Business Innovation Research (SBIR) Program (+$0.292 million). FY 2013: General Congressional Reductions to DHP RDT&E, PE 0607100-Medical Products and Capabilities Enhancement Activities (-$0.021 million). FY 2013: Congressional Directed Reductions (Sequestration) to DHP RDT&E, PE 0607100-Medical Products and Capabilities Enhancement Activities (-$7.325 million). FY 2014: Realignment from Defense Health Program, Research, Development, Test and Evaluation (DHP RDT&E), PE 0607100-Medical Products and Capabilities Enhancement Activities (-$0.410 million) to DHP RDT&E PE 0605502-Small Business Innovation Research (SBIR) Program (+$0.410 million). FY 2015: Reduces non-combat injury research funding in order to focus and continue the pace of progress in critical and high priority research areas for DHP RDT&E, PE 0607100-Medical Products and Capabilities Enhancement Activities (-$3.139 million).
- Service Agency Name
- Defense Health Program
Related Documents
- Child Project: GDF-Medical Products and Capabilities Enhancement Activities
- Child Accomplishment: 377A: GDF – Medical Products and Capabilities Enhancement Activities